Alzheimer's Drug Discovery Foundation: Treat FTD Fund (Innovative Clinical Trials for Frontotemporal Degeneration)- LOI

The Treat FTD Fund is a joint effort by the Alzheimer's Drug Discovery Foundation (ADDF) and the Association for Frontotemporal Degeneration (AFTD) to support clinical development of novel or repurposed drugs for FTD disorders. Running clinical trials in FTD patients will enable investigators to identify optimal approaches to targeting this unique patient population. In addition, trials supported by the Treat FTD Fund will complement efforts such as the FTD Biomarkers Initiative and the Accelerating Drug Discovery for FTD program by employing emergent advances in biomarker development and preclinical research.

Funding: $500,000-$2,000,000. (No overhead)

https://www.alzdiscovery.org/research-and-grants/funding-opportunities/clinical-trials-for-ftd